Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer

References

• GuddatiAKOvarian cancer stem cells: elusive targets for chemotherapyMed Oncol20122953400340822638913
   PubMed Web of Science ®Google Scholar
• RocconiRPSullivanPLongBTreatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?Int J Gynecol Cancer201222578679122552832
   PubMed Web of Science ®Google Scholar
• BookmanMAFirst-line chemotherapy in epithelial ovarian cancerClin Obstet Gynecol20125519611322343232
   PubMed Web of Science ®Google Scholar
• MeierWdu BoisAReussATopotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)Gynecol Oncol2009114219920519446314
   PubMed Web of Science ®Google Scholar
• FerreroJMWeberBGeayJFSecond-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trialAnn Oncol200718226326817108151
   PubMed Web of Science ®Google Scholar
• ChenCHLinMLOngPLYangJTNovel multiple apoptotic mechanism of shikonin in human glioma cellsAnn Surg Oncol20121993097310622446899
   PubMed Web of Science ®Google Scholar
• ChenHMWangPHChenSSShikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccineCancer Immunol Immunother201261111989200222527248
   PubMed Web of Science ®Google Scholar
• WienchBEichhornTPaulsenMEfferthTShikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cellsEvid Based Complement Alternat Med2012201272602523118796
   PubMed Web of Science ®Google Scholar
• LongSGuangZhiYBaoJieGShikonin derivatives protect immune organs from damage and promote immune responses in vivo in tumour-bearing micePhytother Res2012261263321538626
   PubMed Web of Science ®Google Scholar
• ZareKhKhosrowshahliMNazemiyehHMovafeghiAAzarAMOmidiYCallus culture of Echium italicum L. towards production of a shikonin derivativeNat Prod Res201125161480148720635302
   PubMed Web of Science ®Google Scholar
• ZareKNazemiyehHMovafeghiABioprocess engineering of Echium italicum L: induction of shikonin and alkannin derivatives by two-liquid-phase suspension culturesPlant Cell Tissue Organ Cult20101002157164
   Web of Science ®Google Scholar
• LiWLiuJZhaoYPKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cellsMol Carcinog Epub12192012
   Web of Science ®Google Scholar
• ChenJXieJJiangZWangBWangYHuXShikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2Oncogene201130424297430621516121
   PubMed Web of Science ®Google Scholar
• WuZWuLLiLTashiroSOnoderaSIkejimaTp53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cellsJ Pharmacol Sci200494216617614978355
   PubMed Web of Science ®Google Scholar
• NamKNSonMSParkJHLeeEHShikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-kappaB: neuroprotective implicationsNeuropharmacology200855581982518657551
   PubMed Web of Science ®Google Scholar
• DanhierFFeronOPréatVTo exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug deliveryJ Control Release2010148213514620797419
   PubMed Web of Science ®Google Scholar
• OmidiYDavaranSImpacts of biodegradable polymers: towards biomedical applicationsSharmaSKMudhooAClarkJHA Handbook of Applied Biopolymer Technology: Synthesis, Degradation and ApplicationsLondonRoyal Society of Chemistry2011388418
   Google Scholar
• OmidiYSmart multifunctional theranostics: simultaneous diagnosis and therapy of cancerBioimpacts20111314514723678419
   PubMedGoogle Scholar
• MoogueeMOmidiYDavaranSSynthesis and in vitro release of adriamycin from star-shaped poly(lactide-co-glycolide) nano- and microparticlesJ Pharm Sci20109983389339720229603
   PubMed Web of Science ®Google Scholar
• ThamakeSIRautSLGryczynskiZRanjanAPVishwanathaJKAlendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancerBiomaterials201233297164717322795543
   PubMed Web of Science ®Google Scholar
• DavaranSOmidiYRashidiMRPreparation and in vitro evaluation of linear and star-branched PLGA nanoparticles for insulin deliveryJ Bioact Compat Polym2008232115131
   Web of Science ®Google Scholar
• OmidiYBararJHeidariHRAhmadianSYazdiHAAkhtarSMicroarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial a549 cellsToxicol Mech Methods200818436937820020904
   PubMed Web of Science ®Google Scholar
• OmidiYBararJInduction of human alveolar epithelial cell growth factor receptors by dendrimeric nanostructuresInt J Toxicol200928211312219482835
   PubMed Web of Science ®Google Scholar
• KafilVOmidiYCytotoxic impacts of linear and branched polyethylenimine nanostructures in A431 cellsBioimpacts201111233023678404
   PubMedGoogle Scholar
• ZhaoANunez-CruzSLiCCoukosGSiegelDLSchollerNRapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platformJ Immunol Methods2011363222123220837020
   PubMed Web of Science ®Google Scholar
• Barzegar-JalaliMAdibkiaKValizadehHKinetic analysis of drug release from nanoparticlesJ Pharm Pharm Sci200811116717718471378
   PubMed Web of Science ®Google Scholar
• BararJOmidiYSurface modified multifunctional nanomedi-cines for simultaneous imaging and therapy of cancerBioimpacts201441314
   PubMedGoogle Scholar
• VichaiVKirtikaraKSulforhodamine B colorimetric assay for cytotoxicity screeningNat Protoc2006131112111617406391
   PubMed Web of Science ®Google Scholar
• VermesIHaanenCSteffens-NakkenHReutelingspergerCA novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin VJ Immunol Methods1995184139517622868
   PubMed Web of Science ®Google Scholar
• BararJOmidiYTranslational approaches towards cancer gene therapy: Hurdles and hopesBioimpacts20122312714323678451
   PubMedGoogle Scholar
• BararJOmidiYIntrinsic bio-signature of gene delivery nanocarriers may impair gene therapy goalsBioimpacts20133310510924163801
   PubMedGoogle Scholar
• OmidiYHollinsAJDraytonRMAkhtarSPolypropylenimine dendrimer-induced gene expression changes: the effect of complexation with DNA, dendrimer generation and cell typeJ Drug Target200513743144316308212
   PubMed Web of Science ®Google Scholar
• OmidiYHollinsAJBenboubetraMDraytonRBenterIFAkhtariSToxicogenomics of non-viral vectors for gene therapy: A microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cellsJ Drug Target200311631132314668052
   PubMed Web of Science ®Google Scholar
• BararJHamzeheiHMortazavi TabatabaeiSASEH-AOmidiYGenomic signature and toxicogenomics comparison of polycationic gene delivery nanosystems in human alveolar epithelial A549 cellsDaru J Pharm sci2009173139147
   Web of Science ®Google Scholar
• AndreopoulouEGaiottiDKimEPegylated liposomal doxorubi-cin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancerAnn Oncol200718471672117301073
   PubMed Web of Science ®Google Scholar
• AdibkiaKBarzegar JalaliMNokhodchiAA review on the methods of preparation of pharmaceutical nanoparticlesPharm Sci2010154303314
   Google Scholar
• SnehalathaMVenugopalKSahaRNBabbarAKSharmaRKEtoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99mDrug Deliv200815527728718763158
   PubMed Web of Science ®Google Scholar
• AvgoustakisKBeletsiAPanagiZEffect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticlesInt J Pharm20032591–211512712787641
   PubMed Web of Science ®Google Scholar
• AmoozgarZParkJLinQYeoYLow molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug deliveryMol Pharm2012951262127022489704
   PubMed Web of Science ®Google Scholar
• YadavKSChuttaniKMishraAKSawantKKEffect of size on the biodistribution and blood clearance of etoposide-loaded PLGA nanoparticlesPDA J Pharm Sci Technol201165213113921502074
   PubMedGoogle Scholar
• HamidiMAzadiARafieiPPharmacokinetic consequences of pegylationDrug Deliv200613639940917002967
   PubMed Web of Science ®Google Scholar
• VitorinoPMeyerTModular control of endothelial sheet migrationGenes Dev200822233268328119056882
   PubMed Web of Science ®Google Scholar
• HuangCLuoYZhaoJShikonin kills glioma cells through necroptosis mediated by RIP-1PLoS One201386e6632623840441
   PubMed Web of Science ®Google Scholar
• Conejo-GarciaJRBuckanovichRJBenenciaFVascular leukocytes contribute to tumor vascularizationBlood2005105267968115358628
   PubMed Web of Science ®Google Scholar
• NandaASt CroixBTumor endothelial markers: new targets for cancer therapyCurr Opin Oncol2004161444914685092
   PubMed Web of Science ®Google Scholar
• ChristianSWinklerRHelfrichIEndosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cellsAm J Pathol2008172248649418187565
   PubMed Web of Science ®Google Scholar
• BagleyRGHonmaNWeberWEndosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularizationMicrovasc Res200876318018818761022
   PubMed Web of Science ®Google Scholar
• Carson-WalterEBWinansBNWhitemanMCCharacterization of TEM1/endosialin in human and murine brain tumorsBMC Cancer2009941719948061
   PubMed Web of Science ®Google Scholar
• NandaAKarimBPengZTumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumorsProc Natl Acad Sci USA200610393351335616492758
   PubMed Web of Science ®Google Scholar
• HanWXieJLiLLiuZHuXNecrostatin-1 reverts shikonin-induced necroptosis to apoptosisApoptosis200914567468619288276
   PubMed Web of Science ®Google Scholar
• XuanYHuXNaturally-occurring shikonin analogues – a class of necroptotic inducers that circumvent cancer drug resistanceCancer Lett2009274223324219027226
   PubMed Web of Science ®Google Scholar
• HanWLiLQiuSShikonin circumvents cancer drug resistance by induction of a necroptotic deathMol Cancer Ther2007651641164917513612
   PubMed Web of Science ®Google Scholar
• ChenXYangLOppenheimJJHowardMZCellular pharmacology studies of shikonin derivativesPhytother Res200216319920912164262
   PubMed Web of Science ®Google Scholar